Serum C-Reactive Protein (CRP) Levels and Insulin Resistance in Non-Obese Women with Polycystic Ovarian Syndrome, and Effect of Bicalutamide on Hirsutism, CRP Levels and Insulin Resistance

@article{Baheci2004SerumCP,
  title={Serum C-Reactive Protein (CRP) Levels and Insulin Resistance in Non-Obese Women with Polycystic Ovarian Syndrome, and Effect of Bicalutamide on Hirsutism, CRP Levels and Insulin Resistance},
  author={Mithat Bahçeci and Alpaslan Kemal Tuzcu and Naime Canoruç and Yekta Tuzun and Veysel Kıdır and Cetin Aslan},
  journal={Hormone Research in Paediatrics},
  year={2004},
  volume={62},
  pages={283 - 287}
}
Background/Aims: Insulin resistance is associated with serum C-reactive protein (CRP) levels. We aimed to evaluate the effect of bicalutamide on insulin resistance and serum CRP levels in non-obese polycystic ovarian syndrome (PCOS) patients. Methods: 40 non-obese patients (BMI ≤25 kg/m2) with PCOS and, 40 age- and BMI-matched healthy women were studied. Patients received bicalutamide orally at the dose of 25 mg/day. Serum CRP levels were measured with immunometric assay. Homeostasis model… Expand
Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome.
TLDR
The aim of this study was to evaluate the serum concentrations of high sensitivity C-reactive protein (hsCRP), a non-specific marker of low-grade inflammation and a predictive marker for cardiovascular disease, in normal weight women with PCOS. Expand
Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome
TLDR
Circulating resistin levels may not be candidate to play a role in pathogenesis of PCOS without insulin resistance or obesity, whereas adiponectin level in non-obese young women with PCOS was significantly higher than control subjects, perhaps, because of no insulin resistance. Expand
Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
TLDR
CRP could differentiate between women with and without increased cardiovascular risk at a cut-off value of 2.42 mg/l, with a sensitivity of 79% and a specificity of 81%. Expand
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
TLDR
Findings imply the presence of chronic inflammation in women with PCOS, as metformin decreases the levels of plasma inflammatory indices. Expand
Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome.
TLDR
Women with PCOS have increased serum concentrations of CVD risk markers compared with controls, yet with significant between-study heterogeneity, to provide high-quality evidence on the relation between PCOS and CVD. Expand
The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
TLDR
Existence of insulin resistance alone may not be an adequate factor for deterioration of endothelial function and carotid IMT in young, nonobese patients with PCOS, and other factors may play an important role in this process. Expand
Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
TLDR
Overall, PCOS management remains focused on specific targets including assessment and treatment of cardiometabolic risk, according to disease phenotypes. Expand
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.
TLDR
Women with PCOS exhibit an elevation in circulating CRP that is independent of obesity, which corroborates existing molecular evidence of the chronic low-grade inflammation that may underpin the pathogenesis of this disorder. Expand
Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment
TLDR
Quercetin improved IR and demonstrated a favorable therapeutic effect on the PCOS rats and the underlying mechanism potentially involves the inhibition of the Toll-like receptor/NF-κB signaling pathway and the improvement in the inflammatory microenvironment of the ovarian tissue of the insulin-resistant PCOS rat model. Expand
Polycystic ovary syndrome and hyperprolactinemia are distinct entities
TLDR
It is concluded that PCOS patients with increased PRL levels must be investigated for other causes of hyperprolactinemia, because hyper Prolactin levels are not a clinical manifestation of PCOS. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 24 REFERENCES
Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome?
TLDR
PCOS is associated with insulin resistance; non-obese hyperprolactinemic PCOS patients may be more insulin-resistant than normoprolactinemics and there may be an association between hyperproLactinemia and insulin resistance in PCOS. Expand
Low grade chronic inflammation in women with polycystic ovarian syndrome.
TLDR
It is proposed that women with PCOS have significantly increased CRP concentrations relative to women with normal menstrual rhythm and normal androgen levels, which is a novel mechanism contributing to increased risk of CHD and type 2 diabetes in these women. Expand
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
TLDR
PCOS women are at significantly increased risk for IGT and type 2 diabetes mellitus at all weights and at a young age; these prevalence rates are similar in 2 different populations of PCOS women, suggesting that PCOS may be a more important risk factor than ethnicity or race for glucose intolerance in young women. Expand
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.
TLDR
Antiandrogen treatment partially reversed the peripheral insulin resistance associated with hyperandrogenism regardless of which antiandrogen was used, suggesting that in women, androgen excess per se contributes to impairment of insulin action. Expand
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.
TLDR
In prospective data from a large cohort of apparently healthy men, baseline CRP level added to the predictive value of lipid parameters in determining risk of first MI. Expand
Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome.
TLDR
In both lean and obese PCO women, treatment with flutamide for 1 or 3 months markedly improved the clinical and biochemical androgenic features, but did not significantly influence the overall insulin sensitivity, indicating that PCO and obesity exert synergistic effects on insulin resistance. Expand
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
TLDR
An independent relationship of 2 crucial factors of hemostasis, fibrinogen and PAI-1, to insulin and its precursors is demonstrated, which may have important clinical implications in the risk assessment and prevention of macrovascular disease. Expand
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
TLDR
The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events. Expand
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
TLDR
In a consecutive population of unselected women the prevalence of hirsutism varied from 2-8% depending on the chosen cut-off F-G score, with no significant difference between White and Black women. Expand
Production of C-reactive protein and risk of coronary events in stable and unstable angina
TLDR
It is found that raised circulating concentrations of CRP are predictors of coronary events in patients with stable or unstable angina and may be useful in the management of coronary heart disease. Expand
...
1
2
3
...